Latest Breaking News On - Ben burton - Page 16 : comparemela.com

Press release content from PR Newswire. The AP news staff was not involved in its creation. LumiThera Announces Top Line Data in the European Multi-Center, LIGHTSITE II Clinical Study to Treat Dry Age-Related Macular Degeneration April 7, 2021 GMT SEATTLE, April 7, 2021 /PRNewswire/ LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and disease, today announced positive findings in its LIGHTSITE II, multi-center clinical trial in dry Age-Related Macular Degeneration (AMD) patients. The prospective, double-masked, randomized, multi-center, European Union post-marketing clinical trial, titled LIGHTSITE II, was conducted in eight leading retinal centers based in the United Kingdom, Germany, Spain, Italy and France. The objective was to treat dry AMD subjects over the course of three rounds of PBM sessions every four months with a duration of 10 months. The study was converted to a smaller pilot as some of th

Comunidad autonoma de catalunaUnited statesUnited kingdomSchleswig holsteinClark tedfordMarion munkBen burtonJames paget university hospitalEuropean unionFood drug administrationBern photographic reading centerPrnewswire lumithera incLumithera incThera incAge related macular degenerationMedical director